Tirzepatide is a dual active agonist of both Glucagon-like Peptide-1 (GLP-1) and Glucosedependent Insulinotropic Polypeptide (GIP) receptors. It acts as an incretin hormone with important effects on glycemic control and body weight regulation, particularly relevant in people with Type-II Diabetes (T2D). Tirzepatide is used as active component of Mounjaro?.
This ELISA was developed with serum from rabbits immunized with Tirzepatide coupled to a carrier protein.